Skip to content

Basket

You currently have no items in your basket.

Total (excl. vat) £0.00
View basket & checkout
Antibodies

ATF4 Antibody, Clone N360A/24: HRP

Product Sizes
100 ug
£494.00
SMC-447D-HRP-100UG
About this Product
SKU:
SMC-447D-HRP
Additional Names:
Ataxin 1, Ataxin-1, ATX1, Atxn1, D6S504E, OTTHUMP00000016065, SCA1, Spinocerebellar ataxia type 1 protein
Application:
Immunocytochemistry, Immunofluorescence, Immunohistochemistry, Western Blot
Buffer:
73.64mM Carbonate, 54.55mM Ethanolamine, 45.45mM Cyanoborohydride, 18.18mM Sodium Hydroxide 0.23mM Citrate
CE/IVD:
Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.
translate.label.attr.clone:
N360A/24 (Formerly sold as S360A-24)
Clonality:
Monoclonal
Conjugate:
HRP
Concentration:
1 mg/ml
Extra Details:
Activating Transcription Factor 4 (ATF4) is a key basic leucine zipper (bZIP) transcription factor that orchestrates cellular responses to endoplasmic reticulum (ER) stress, oxidative stress, and nutrient deprivation-conditions commonly implicated in neurodegenerative diseases. ATF4 regulates critical pathways including amino acid metabolism, DNA damage repair, chromatin remodeling, and apoptosis, positioning it as a central node in maintaining neuronal homeostasis. In the nervous system, ATF4 functions as a stress-responsive transcriptional regulator, often in coordination with proteins such as CHOP (C/EBP homologous protein), asparagine synthetase (ASNS), and cAMP response elements (CREs). These interactions modulate gene expression programs that determine cell survival or death under pathological conditions. Notably, ATF4 suppresses pancreatic B Beta-cell proliferation and insulin production, linking metabolic dysfunction to neurodegenerative processes. ATF4 also influences epigenetic regulation by targeting the histone demethylase JMJD3, thereby altering chromatin architecture and enhancing transcriptional responses to amino acid scarcity. This epigenetic control is particularly relevant in neurons, where adaptive gene expression is essential for coping with chronic stress. Given its multifaceted role in stress signaling, ATF4 is increasingly recognized as a therapeutic target in neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease, and amyotrophic lateral sclerosis (ALS). Ongoing research into ATF4-mediated pathways offers promising insights into the molecular mechanisms driving neuronal vulnerability and resilience.
Host:
Mouse
Immunogen:
Fusion protein amino acids 25-327 of human ATF4. 86% identical to rat, and 85% identical to mouse. <50% identity with ATF5.
Isotype:
IgG2a
Purification:
Protein G Purified
Reactivities:
Human, Rat
Shipping Conditions:
Blue Ice
Specificity:
Detects ~60kDa. Does not cross-react with ATF5.
Storage Conditions:
See Manual
Supplier:
StressMarq Biosciences
Type:
Antibody: Monoclonal Antibody